Literature DB >> 10502403

Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin.

C A Gaudry1, E Verderio, R A Jones, C Smith, M Griffin.   

Abstract

We recently reported [J. Cell Sci. 110, 2461-2472 (1997)] that reduced expression of tissue transglutaminase (tTgase, type II) in human endothelial cell line ECV304 led to impaired cell spreading and adhesion; however, there is no immunocytochemical evidence for its presence and specific location at the surface of these cells. In this report we have stably transfected the same cell line with the cDNA for human tTgase which has been tagged at the C-terminus of the encoded protein with a 12-amino-acid peptide from protein kinase C epsilon. Using antibodies directed against this epitope tag peptide we show for the first time using immunogold electron microscopy and fluorescent immunocytochemistry the presence of cell surface-related tTgase. In cells undergoing attachment and cell spreading the enzyme appears to be concentrated at cell adhesion points which are rich in beta(1) integrin, suggesting that these areas may be the initial focal points for enzyme externalization. In more spread and confluent cells the enzyme appears more diffusely distributed along the basal membrane, with increased concentrations found at areas of cell-cell and cell-substratum contact. These findings strengthen the argument for the enzyme's role in cell-matrix interactions. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502403     DOI: 10.1006/excr.1999.4633

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding.

Authors:  Greg Byrne; Fergus Ryan; John Jackson; Con Feighery; Jacinta Kelly
Journal:  Gut       Date:  2006-08-25       Impact factor: 23.059

Review 4.  Role of transglutaminase 2 in celiac disease pathogenesis.

Authors:  Cornelius Klöck; Thomas R Diraimondo; Chaitan Khosla
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

Review 5.  Extracellular TG2: emerging functions and regulation.

Authors:  Alexey M Belkin
Journal:  FEBS J       Date:  2011-11-21       Impact factor: 5.542

6.  Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway.

Authors:  Anna Janiak; Evgeny A Zemskov; Alexey M Belkin
Journal:  Mol Biol Cell       Date:  2006-02-01       Impact factor: 4.138

7.  Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells.

Authors:  Clément Faye; Antonio Inforzato; Marine Bignon; Daniel J Hartmann; Laurent Muller; Lionel Ballut; Bjorn R Olsen; Anthony J Day; Sylvie Ricard-Blum
Journal:  Biochem J       Date:  2010-04-14       Impact factor: 3.857

8.  Use of tissue transglutaminase and fibronectin to influence osteoblast responses to tricalcium phosphate scaffolds.

Authors:  M D Ball; D O'Connor; A Pandit
Journal:  J Mater Sci Mater Med       Date:  2008-08-14       Impact factor: 3.896

9.  Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.

Authors:  Dilek Telci; Russell John Collighan; Huveyda Basaga; Martin Griffin
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

Review 10.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.